After a break with Philidor, outlook from Valeant is more guarded

Embattled Valeant Pharmaceuticals is slashing its expectations for the current quarter and 2015 as a whole and issuing a guarded outlook for next year as well.

See Full Article

Valeant is lowering its per-share profit expectations for the year, reported in U.S. currency, from between $11.67 and $11.87, to between $10.23 and $10.33. That's well short of the analyst estimates.

The drugmaker's outlook for the fourth quarter ending Dec. 31 has been lowered to between $2.55 and $2.65 a share. Analysts expected $3.47 per share and the company's previous estimate was between $4.00 and $4.20 per share.

Valeant's press release didn't specify the reason for the reduced expectations -- which come as the Quebec-based company faces investor dissatisfaction over its handling of a controversy over its pricing and distribution practices, which are being investigated by U.S. authorities.

Chief executive Michael Pearson and other Valeant executives will face questions from analysts at a company briefing this morning.

In October, the Quebec-based company severed ties with a U.S. mail-order pharmacy that distributed specialty drugs for Valeant. It also announced on Tuesday that it will deliver up to US$600 million in annual savings to the U.S. health-care system starting next year after agreeing to cut prices as part of distribution agreements with the large Walgreens retail chain.

Valeant says it will drop wholesale prices for branded prescription-based skin and eye-care products by 10 per cent. Walgreens will also distribute more than 30 of Valeant's branded products at comparable generic prices, starting in the second half of 2016. The average price decrease is expected to be more than 50 per cent, and range between five and 95 per cent.

The company's shares are already down more than 20 per cent for the year, closing Tuesday at C$149.75 on the Toronto Stock Exchange.

Valeant's price cuts don't apply in Canada where the Laval-based company doesn't have similar distribution agreements with pharmacy retailers such as Shopper's Drug Mart, Jean Coutu or the Rexall Group.

The new distribution agreement with Walgreens -- a chain with more than 8,000 retail outlets -- follows Valeant's decision in October to sever ties with mail-order pharmacy Philidor Rx Services. That relationship came to light as a result of a court battle between Valeant and another mail-order pharmacy.

Valeant has been accused of using Philidor to create a network of "phantom pharmacies" to steer pharmacy benefit managers toward Valeant's more expensive drugs, rather than cheaper alternatives.

With files from The Associated Press and the Canadian Press.



Advertisements

Latest Economic News

  • Inflammatory letter sheds light on Uber's alleged misconduct

    Economic CTV News
    SAN FRANCISCO -- A former Uber security specialist accused the company of dispatching a team of spies to steal its rivals' trade secrets and using shady tactics to thwart its competition in the ride-hailing market, according an inflammatory letter unsealed Friday by a federal judge. Source
  • Court denies WestJet's bid to toss harassment lawsuit filed by former worker

    Economic CTV News
    VANCOUVER -- WestJet has lost a bid to throw out of court a proposed class-action lawsuit that accuses the company of failing to provide a harassment-free workplace for women. Former flight attendant Mandalena Lewis sued WestJet (TSX:WJA) in the Supreme Court of British Columbia over allegations of gender-based discrimination, accusing her former employer of fostering a corporate culture that tolerates harassment against female employees. Source
  • Toronto stock index shows moderate gain in broad-based advance, loonie drops

    Economic CTV News
    TORONTO -- Canada's main stock index moved forward today in a broad-based advance, while those on Wall Street closed at record highs. The Toronto Stock Exchange's S&P/TSX composite index gained 25.52 points to 16,041.98, led by a double-digit jump in the worth of Linamar Corp. Source
  • Apotex founder Barry Sherman, wife found dead in Toronto home

    Economic CBC News
    Canadian pharmaceutical giant Apotex has confirmed its founder Barry Sherman and his wife, Honey, are dead, amid reports that two bodies were found in their Toronto home. "All of us at Apotex are deeply shocked and saddened by this news and our thoughts and prayers are with the family at this time," the company said in a statement late Friday afternoon, adding that the deaths were "unexpected. Source
  • Apotex founder Barry Sherman and wife found dead in Toronto home

    Economic CBC News
    Canadian pharmaceutical giant Apotex has confirmed its founder Barry Sherman and his wife, Honey, are dead, amid reports that two bodies were found in their Toronto home. "All of us at Apotex are deeply shocked and saddened by this news and our thoughts and prayers are with the family at this time," the company said in a statement late Friday afternoon, adding that the deaths were "unexpected. Source
  • Bitcoin price nears $18,000 US as second futures contract set to start trading

    Economic CBC News
    Bitcoin blasted to another all-time high of almost $18,000 US on the Bitstamp exchange on Friday, up 9 per cent on the day, as warnings grew over the risks of investing in the highly volatile and speculative instrument. Source
  • Bombardier, Boeing prepare to make final arguments in bitter trade dispute

    Economic CTV News
    OTTAWA -- The bitter dispute between Bombardier and Boeing will enter a critical phase next week, when the two aerospace rivals appear before an all-important trade tribunal -- whose ruling will ultimately decide the fight. Source
  • H&M to close more stores as customers go online

    Economic CTV News
    Swedish clothing giant Hennes & Mauritz on Friday said sales fell below expectations in the fourth quarter and it would close more stores as customers increasingly prefer to shop online. H&M CEO Karl-Johan Persson said in a statement that the company's "online sales and sales of the group's other brands continued to develop well" but that physical stores "were negatively affected by a continued challenging market situation with reduced footfall to stores due to the ongoing shift in the…
  • Oilsands price discounts expected to rise as output exceeds export pipeline room

    Economic CTV News
    CALGARY -- An RBC report warns that Canadian oilsands producers face rising price discounts as growing production "materially exceeds" export pipeline capacity to the United States in the first quarter of 2018. RBC Dominion Securities says production from the oilsands of northern Alberta is set to climb by nearly 620,000 barrels per day over the next four years to 3.3 million barrels per day in 2021 before levelling off. Source
  • NAFTA uncertainty weighing on Canadian business confidence: EDC

    Economic CBC News
    Export Development Canada said Friday that 23 per cent of Canadian exporters surveyed recently say the ongoing NAFTA negotiations are having a negative impact on their operations. The figure is contained in the latest release of EDC's semi-annual trade confidence report, which found that Canadian exporters' overall confidence in domestic and international sales opportunities over the next six months was down only slightly from the spring despite a weaker Canadian dollar and softer merchandise…